D-Index & Metrics Best Publications
Molecular Biology
Sweden
2023
Genetics and Molecular Biology
Sweden
2022

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Molecular Biology D-index 83 Citations 34,301 303 World Ranking 541 National Ranking 10

Research.com Recognitions

Awards & Achievements

2023 - Research.com Molecular Biology in Sweden Leader Award

2022 - Research.com Genetics and Molecular Biology in Sweden Leader Award

Member of the European Molecular Biology Organization (EMBO)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Enzyme

His scientific interests lie mostly in DNA repair, Molecular biology, DNA replication, Homologous recombination and DNA damage. His DNA repair study integrates concerns from other disciplines, such as Replication protein A, Cancer research and Poly ADP ribose polymerase, PARP1. His Molecular biology study combines topics from a wide range of disciplines, such as Base excision repair, Genetic recombination, Histone code, Histone H2A and Gene conversion.

His DNA replication research includes themes of Cell cycle, Chromosome instability, Aneuploidy and Cell biology. Thomas Helleday has researched Homologous recombination in several fields, including Gene duplication, Homology directed repair, Postreplication repair and Poly Polymerase Inhibitor. His biological study spans a wide range of topics, including Cancer cell, Senescence, DNA fragmentation and Pharmacology.

His most cited work include:

  • Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (3289 citations)
  • Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase (3289 citations)
  • Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints (1500 citations)

What are the main themes of his work throughout his whole career to date?

DNA repair, DNA damage, Cancer research, Molecular biology and DNA are his primary areas of study. His research integrates issues of Poly ADP ribose polymerase and Poly Polymerase Inhibitor in his study of DNA repair. His DNA damage research integrates issues from G2-M DNA damage checkpoint, DNA mismatch repair, DNA replication and Cell biology.

The study incorporates disciplines such as Cancer cell, Cancer, Apoptosis, Programmed cell death and Downregulation and upregulation in addition to Cancer research. The various areas that Thomas Helleday examines in his Molecular biology study include Replication protein A, Nucleotide excision repair, Homologous recombination and Proliferating cell nuclear antigen. His Homologous recombination research focuses on Genetic recombination and how it connects with High-mobility group.

He most often published in these fields:

  • DNA repair (58.11%)
  • DNA damage (41.22%)
  • Cancer research (39.41%)

What were the highlights of his more recent work (between 2018-2021)?

  • Cancer research (39.41%)
  • DNA (36.04%)
  • DNA damage (41.22%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Cancer research, DNA, DNA damage, Cancer cell and Biochemistry. Thomas Helleday interconnects Base excision repair, DNA repair, Cancer and Apoptosis in the investigation of issues within Cancer research. His work carried out in the field of DNA repair brings together such families of science as Polymerase, Poly ADP ribose polymerase, Homologous recombination, Proteomics and Messenger RNA.

He combines subjects such as Nucleotide and Cell biology with his study of DNA. DNA damage is frequently linked to Protein subunit in his study. His studies in Mitosis integrate themes in fields like Cell cycle and DNA replication.

Between 2018 and 2021, his most popular works were:

  • Managing COVID-19 in the oncology clinic and avoiding the distraction effect. (88 citations)
  • Managing COVID-19 in the oncology clinic and avoiding the distraction effect. (88 citations)
  • The DNA Damaging Revolution: PARP Inhibitors and Beyond. (60 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Enzyme

Thomas Helleday mostly deals with Cancer research, DNA, DNA repair, DNA damage and Cancer cell. His work deals with themes such as Cancer, Chemotherapy induced, Immunotherapy and Cell culture, which intersect with Cancer research. As a part of the same scientific family, Thomas Helleday mostly works in the field of DNA, focusing on Cell biology and, on occasion, In vitro and Mechanism of action.

Thomas Helleday performs multidisciplinary study on DNA repair and Somatic hypermutation in his works. Thomas Helleday has included themes like Poly ADP ribose polymerase and Pharmacology in his DNA damage study. His Cancer cell study integrates concerns from other disciplines, such as Polymerase, Homologous recombination, Transcriptome, Proteomics and Messenger RNA.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

Helen E. Bryant;Nilklas Schultz;Huw D. Thomas;Kayan M. Parker.
Nature (2005)

4863 Citations

Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints

Jirina Bartkova;Nousin Rezaei;Michalis Liontos;Panagiotis Karakaidos.
Nature (2006)

2088 Citations

DNA repair pathways as targets for cancer therapy

Thomas Helleday;Eva Petermann;Cecilia Lundin;Ben Hodgson.
Nature Reviews Cancer (2008)

1774 Citations

DNA double-strand break repair: from mechanistic understanding to cancer treatment.

Thomas Helleday;Justin Lo;Dik C. van Gent;Bevin P. Engelward.
DNA Repair (2007)

806 Citations

Hydroxyurea-Stalled Replication Forks Become Progressively Inactivated and Require Two Different RAD51-Mediated Pathways for Restart and Repair

Eva Petermann;Manuel Luís Orta;Manuel Luís Orta;Natalia Issaeva;Niklas Schultz.
Molecular Cell (2010)

788 Citations

Mechanisms underlying mutational signatures in human cancers

Thomas Helleday;Saeed Eshtad;Serena Nik-Zainal.
Nature Reviews Genetics (2014)

772 Citations

Replication stress links structural and numerical cancer chromosomal instability

Rebecca A. Burrell;Sarah E. McClelland;David Endesfelder;Petra Groth.
Nature (2013)

741 Citations

The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

Thomas Helleday;Thomas Helleday;Thomas Helleday.
Molecular Oncology (2011)

731 Citations

Replication stress links structural and numerical cancer chromosomal instability (vol 494, pg 492, 2013)

RA Burrell;SE McClelland;D Endesfelder;P Groth.
Nature (2013)

718 Citations

The cell-cycle checkpoint kinase Chk1 is required for mammalian homologous recombination repair

Claus Storgaard Sørensen;Lasse Tengbjerg Hansen;Jaroslaw Dziegielewski;Randi G. Syljuåsen.
Nature Cell Biology (2005)

696 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Thomas Helleday

Jiri Bartek

Jiri Bartek

Science for Life Laboratory

Publications: 87

Vassilis G. Gorgoulis

Vassilis G. Gorgoulis

National and Kapodistrian University of Athens

Publications: 85

Alan Ashworth

Alan Ashworth

University of California, San Francisco

Publications: 78

Yves Pommier

Yves Pommier

National Institutes of Health

Publications: 74

Robert G. Bristow

Robert G. Bristow

University of Manchester

Publications: 68

Christopher J. Lord

Christopher J. Lord

Institute of Cancer Research

Publications: 67

Alan D. D'Andrea

Alan D. D'Andrea

Harvard University

Publications: 61

Shunichi Takeda

Shunichi Takeda

Kyoto University

Publications: 56

Keith W. Caldecott

Keith W. Caldecott

University of Sussex

Publications: 51

Jos Jonkers

Jos Jonkers

Antoni van Leeuwenhoek Hospital

Publications: 46

David M. Wilson

David M. Wilson

AstraZeneca (United Kingdom)

Publications: 42

Charles Swanton

Charles Swanton

The Francis Crick Institute

Publications: 42

Stephen P. Jackson

Stephen P. Jackson

University of Cambridge

Publications: 41

Vilhelm A. Bohr

Vilhelm A. Bohr

National Institutes of Health

Publications: 39

Ian D. Hickson

Ian D. Hickson

University of Copenhagen

Publications: 38

Kum Kum Khanna

Kum Kum Khanna

QIMR Berghofer Medical Research Institute

Publications: 38

Trending Scientists

Ronald A. Roy

Ronald A. Roy

University of Oxford

P. John Clarkson

P. John Clarkson

University of Cambridge

Ran Ran

Ran Ran

Nanjing Tech University

Dennis C. Johnson

Dennis C. Johnson

Iowa State University

Xin Jiang

Xin Jiang

Chinese Academy of Sciences

Yihe Zhang

Yihe Zhang

China University of Geosciences

Daniel F. Schorderet

Daniel F. Schorderet

University of Lausanne

Howard V. Cornell

Howard V. Cornell

University of California, Davis

Xochitl Hernandez-Velasco

Xochitl Hernandez-Velasco

National Autonomous University of Mexico

Heidi E. Hamm

Heidi E. Hamm

Vanderbilt University

Scott R. Paterson

Scott R. Paterson

University of Southern California

John Longhi

John Longhi

Lamont-Doherty Earth Observatory

Jonathan A. Stamford

Jonathan A. Stamford

Royal London Hospital

Femmie Juffer

Femmie Juffer

Leiden University

Predrag Petrovic

Predrag Petrovic

Karolinska Institute

Craig S. Holt

Craig S. Holt

University of Iowa

Something went wrong. Please try again later.